On February 2, 2024, the “gang of six” a bipartisan group of six senators who have traditionally championed reforms to the 340B program1 introduced a discussion draft of a bill that.
The US Food and Drug Administration (FDA) on February 1 issued a draft guidance, “Formal Meetings Between FDA and Sponsors or Requestors of OTC Monograph Drugs” (Meeting Guidance), that.
The US Food and Drug Administration (FDA) on February 1 issued a draft guidance, "Formal Meetings Between FDA and Sponsors or Requestors of OTC Monograph Drugs" (Meeting Guidance).